Exploring the cost-effectiveness of EBV vaccination to prevent multiple sclerosis in an Australian setting

Conclusions
MS prevention using future EBV vaccinations, particularly targeted at adolescence population, is highly likely to be cost-effective.

Source: Journal of Neurology, Neurosurgery and Psychiatry - April 12, 2024 Category: Neurosurgery Authors: Palmer, A. J., Zhao, T., Taylor, B. V., van der Mei, I., Campbell, J. A. Tags: Multiple sclerosis Source Type: research